These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 1449432)

  • 1. Carboplatin and cisplatin ototoxicity in guinea pigs.
    Taudy M; Syka J; Popelár J; Ulehlová L
    Audiology; 1992; 31(5):293-9. PubMed ID: 1449432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cochlear structure and function after round window application of ototoxins.
    Bauer CA; Brozoski TJ
    Hear Res; 2005 Mar; 201(1-2):121-31. PubMed ID: 15721567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High accumulation of platinum-DNA adducts in strial marginal cells of the cochlea is an early event in cisplatin but not carboplatin ototoxicity.
    Thomas JP; Lautermann J; Liedert B; Seiler F; Thomale J
    Mol Pharmacol; 2006 Jul; 70(1):23-9. PubMed ID: 16569706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative studies of the ototoxicity of cisplatin and carboplatin].
    Delb W; Feilen S; Koch A; Federspil P
    Laryngorhinootologie; 1993 Jan; 72(1):24-7. PubMed ID: 8439352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery of hearing following cisplatin ototoxicity in the guinea pig.
    O'Leary SJ; Klis SF
    Anticancer Res; 2002; 22(3):1525-8. PubMed ID: 12168832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of antioxidants in protection from ototoxic drugs.
    Sergi B; Fetoni AR; Ferraresi A; Troiani D; Azzena GB; Paludetti G; Maurizi M
    Acta Otolaryngol Suppl; 2004 May; (552):42-5. PubMed ID: 15219046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hearing loss in children with brain tumors treated with cisplatin and carboplatin-based high-dose chemotherapy with autologous bone marrow rescue.
    Freilich RJ; Kraus DH; Budnick AS; Bayer LA; Finlay JL
    Med Pediatr Oncol; 1996 Feb; 26(2):95-100. PubMed ID: 8531860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perilymphatic application of alpha-melanocyte stimulating hormone ameliorates hearing loss caused by systemic administration of cisplatin.
    Wolters FL; Klis SF; Hamers FP; de Groot JC; Smoorenburg GF
    Hear Res; 2004 Mar; 189(1-2):31-40. PubMed ID: 14987750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of platinum in blood and perilymph in relation to cisplatin induced ototoxicity in the guinea pig.
    Sepmeijer JW; Klis SF
    Hear Res; 2009 Jan; 247(1):34-9. PubMed ID: 18955125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semiquantitative analysis by scanning electron microscopy of cochlear hair cell damage by ototoxic drugs.
    Saito T; Manabe Y; Honda N; Yamada T; Yamamoto T; Saito H
    Scanning Microsc; 1995 Mar; 9(1):271-80; discussion 280-1. PubMed ID: 8553022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of selective inner hair cell damage by carboplatin.
    Takeno S; Harrison RV; Mount RJ; Wake M; Harada Y
    Scanning Microsc; 1994 Mar; 8(1):97-106. PubMed ID: 7973504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ionomer cement on guinea pig cochleas.
    Kobayashi T; Hinohira Y; Hyodo M; Bredberg G; Alsterborg E
    Ear Nose Throat J; 1997 Apr; 76(4):223-6, 228, 230. PubMed ID: 9127521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmented ototoxic effect of cisplatin in heterozygotes of the German waltzing guinea pig.
    Skjonsberg A; Bucinskaite V; Laurell G; Ulfendahl M
    Audiol Neurootol; 2008; 13(2):97-104. PubMed ID: 18057873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candidate's thesis: enhancing intrinsic cochlear stress defenses to reduce noise-induced hearing loss.
    Kopke RD; Coleman JK; Liu J; Campbell KC; Riffenburgh RH
    Laryngoscope; 2002 Sep; 112(9):1515-32. PubMed ID: 12352659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
    Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
    Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental study on cisplatinum ototoxicity].
    Li L
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1990 Aug; 25(4):205-7, 254. PubMed ID: 2076323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distortion product otoacoustic emissions: an objective technique for the screening of hearing loss in children treated with platin derivatives.
    Dhooge I; Dhooge C; Geukens S; De Clerck B; De Vel E; Vinck BM
    Int J Audiol; 2006 Jun; 45(6):337-43. PubMed ID: 16777780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ototoxicity of common topical antimycotic preparations.
    Tom LW
    Laryngoscope; 2000 Apr; 110(4):509-16. PubMed ID: 10763995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ototoxicity of carboplatin: comparing animal and clinical models at the Hospital for Sick Children.
    Macdonald MR; Harrison RV; Wake M; Bliss B; Macdonald RE
    J Otolaryngol; 1994 Jun; 23(3):151-9. PubMed ID: 8064951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceleration of cisplatin ototoxicity by perilymphatic application of 4-methylthiobenzoic acid.
    Cappaert NL; Klis SF; Wijbenga J; Smoorenburg GF
    Hear Res; 2005 May; 203(1-2):80-7. PubMed ID: 15855032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.